Atlanta Georgia – Current reports state that Alzheimers is the sixth leading cause of death for all Americans, and the fourth leading cause of death for older Black/African Americans. Additionally, it notes that Black/African American elders are two to three times more likely to have Alzheimers disease compared with Whites. With evidence of this magnitude, we realize an investment to stop, prevent or cure Alzheimers must be accelerated. There is a clear and urgent need to promote informed decisions about health dementia-related preventive behavior in the African American community. The Emory ADRC will strengthen its capacity via educational initiatives and screening and detection efforts by developing culturally sensitive educational materials that are consistent with several objectives of the National Alzheimers Project Act (NAPA) signed into law by President Obama.
Over the years we have used established and innovative strategies to provide information and education regarding early detection and diagnosis issues related to caregiving, and developments in research to reduce racial disparities by:
Disseminating information to the community about risk factors for cognitive impairment that include how to identify early warning signs of memory loss. Offering cognitive screening opportunities to facilitate the diagnosis of disorders that impair thinking.
Providing continuing education hours for nurses, social workers and allied health care professionals. Through internal and external support the Emory ADRC has gained traction and momentum to effect changes in knowledge, attitudes, and behaviors so that individuals become proactive and informed consumers regarding their cognitive health.
As the US elderly population continues to expand rapidly, Alzheimers disease poses a major and increasing public health challenge, and older African Americans may be disproportionately burdened by the disease. Although African Americans were generally underincluded in previous research studies, new and growing evidence suggests that they may be at increased risk of the disease and that they differ from the non-Hispanic white population in risk factors and disease manifestation.
This article offers an overview of the challenges of Alzheimers disease in African Americans, including diagnosis issues, disparities in risk factors and clinical presentation of disease, and community-based recommendations to enhance research with this population. Racial and ethnic differences in the prevalence of Alzheimers and other dementias. Although there are more non-Hispanic whites living with Alzheimers and other dementias than any other racial or ethnic group in the United States, older Black/African Americans and Hispanics are more likely, on a per-capita basis, than older Whites to have Alzheimers or other dementias. Most studies indicate that older Black/African Americans are about twice as likely to have Alzheimers or other dementias as older Whites. Some studies indicate Hispanics are about one and one-half times as likely to have Alzheimers or other dementias as older Whites. Recent studies suggest the increased likelihood for Hispanics may be slightly lower than this, depending upon the specific Hispanic ethnic group observed (for example, Mexican Americans compared with Caribbean Americans).
The higher prevalence of Alzheimers dementia in minorities compared with Whites appears to be due to a higher incidence of dementia in these groups. Variations in health, lifestyle and socioeconomic risk factors across racial groups likely account for most of the differences in risk of Alzheimers and other dementias. Despite some evidence that the influence of genetic risk factors on Alzheimers and other dementias may differ by race, genetic factors do not appear to account for the large differences in prevalence or incidence among racial groups. Instead, health conditions such as cardiovascular disease and diabetes, which are associated with an increased risk for Alzheimers and other dementias, are believed to account for these differences, as they are more prevalent in Black/African-American and Hispanic people. Socioeconomic characteristics, including lower levels of education, higher rates of poverty, and greater exposure to adversity and discrimination, may also increase risk in Black/African-American and Hispanic communities. Some studies suggest that differences based on race and ethnicity do not persist in rigorous analyses that account for such factors. There is evidence that missed diagnoses of Alzheimers and other dementias are more common among older
Black/African Americans and Hispanics than among older Whites. Based on data for Medicare beneficiaries age 65 and older, Alzheimers or another dementia had been diagnosed in 10.3 percent of Whites, 12.2 percent of Hispanics, and 13.8 percent of Black/African Americans. Although rates of diagnosis were higher among Black/African Americans than among Whites, according to prevalence studies that detect all people who have dementia irrespective of their use of the health care system, the rates should be even higher for Black/African Americans. There are fewer data from population-based cohort studies regarding the national prevalence of Alzheimers and other dementias in racial and ethnic groups other than Whites, Black/African Americans, and Hispanics. However, a study examining electronic medical records of members of a large health plan in California indicated that dementia incidence determined by the presence of a dementia diagnosis in members’ medical records was highest in Black/African Americans, intermediate for Latinos (the term used in the study for those who self-reported as Latino or Hispanic) and Whites, and lowest for Asian Americans. A follow-up study with the same cohort showed heterogeneity within Asian-American subgroups, but all subgroups studied had lower dementia incidence than Whites.
A recent systematic review of the literature found that Japanese Americans were the only Asian-American subgroup with reliable prevalence data, and that they had the lowest prevalence of dementia compared with all other ethnic groups. Alzheimers disease continues to be a large and growing public health problem for caregivers and families, health services workers, and policy makers. Occurrence of the disease is strongly related to age, and because the population ages sixty-five and older is growing at a rapid pace, the number of people with dementia is expected to increase significantly in the coming decades. At the same time, the United States is becoming increasingly diverse, particularly among the elderly. In 2010 the US Census Bureau indicated that 20 percent of the US population ages sixty-five and older was a racial or ethnic minority. Current projections suggest that by 2050, 42 percent of the nations older adults will be members of minority groups. Among those ages eighty-five and older, 33 percent are projected to be a minority.
Alzheimer's Message Board 